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TECHNICAL NOTE
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PHILIPPE GALLICE, NANCY FOURNIER, AIME CREVAT, MICHEL BRI0T, RAYMOND FRAYSSINET,
and ANTOINE MURISASCO
Laboratoire de Biophysique, Faculté de Pharmacie, and Centre d'Hémodialyse, Hôpital Sainte Marguerite, Marseille, and Centre de
Recherches Clin-Midy, Montpel/ier, France
Since the hypothesis of Babb et a! [1, 21 concerning the
existence of uremic middle molecules (UMM), it is now known
these substances in the molecular weight range of 300 to 2000
daltons accumulate in body fluids of patients with chronic renal
disease and in normal urine.
Some of these compounds have been found to be peptides [3—
51, and more recently, a double conjugate has been identified
[61. Among one of the first described methods used to separate
middle molecules was FUrst's technique which resorts succes-
sively to gel permeation chromatography and then to anion-
exchange chromatography [7]. But this separation does not
render chemically pure fractions. Therefore, we have devel-
oped a more resolvent method using high performance liquid
chromatography (HPLC).
In this work, we describe the different steps of this technique.
The first steps are preparative procedures derived from Fürst's
analytical technique, followed by fractionation using HPLC.
Methods. Preparation of biological samples. We used biolog-
ical fluids from nine patients who suffered from chronic renal
insufficiency with several etiologies. The patients were treated
by intermittent hemodialysis (7 or 8 hr twice a week or 6 hr
three times a week).
We used plasmatic ultrafiltrates for these patients that were
obtained at the beginning of dialysis by applying negative
pressure in the dialyser compartment of a capillary dialyser
(Cordis Dow Corp., Miami, Florida) fitted with a cellulose
acetate membrane before the dialysis fluid ran through the
dialyser. Moreover, we performed experiments with a pool of
normal serum and a pool of normal urine. The former was
deproteinated by centrifugation through CF25 ultrafiltration
cones with a molecular weight cut-off at 26,000 daltons (Amicon
Corp., Paris,, France): the latter was used after simple filtration.
All samples were stored at —20°C.
Preparative separation of UMM. All experiments were per-
formed at 20°C.
First step. Gel permeation chromatography: The separation
was carried out on a 2.5 x 100cm column (Pharmacia, Uppsala,
Sweden) packed with Sephadex G15. An amount of the sample,
5 to 20 ml, was injected at the top of the column and eluted with
a solution of Tris-HCI 0.01 M buffer (pH 8.6). The eluate flow-
rate of 80 mI/hr was obtained by a peristaitic pump (Minipuls
HP4 Gilson). The eluate was monitored at 254 nm with a
detector (Varian) fitted with an 8-sl microcell, using a fraction
collector (Microcol TDC 80 Gilson) to collect 6 ml of fluid.
Second step. Anion-exchange chromatography: This second
step was performed in a 1.0 x 30cm glass column packed with
DEAE Sephadex A25 (Pharmacia, Uppsala, Sweden). A 30-mi
sample was eluted at a flow-rate of 15 mI/hr with a solution of
Tris-HCI 0.01 M buffer (pH 8.6) containing a sodium chloride
concentration increasing from 0 to 0.15 M.
At any time (t) the sodium chloride concentration was
C1 = Cf (i — e)
where C1 represents the sodium chloride concentration at time
t; Cf, the final sodium chloride concentration (0.15 M); Q, flow-
rate; v, volume of the gradient mixing chamber (125 ml).
The detection of the eluate was carried out continuously at
254 nm (LKB, Uvicord S,70 l cell) and collected in 6-mi
aliquots.
Third step. Fraction desalting: Fractions were desaited by gel
permeation chromatography in a 1.0 x 100 cm glass column
packed with Sephadex Gl5, using bidistilled water as an eluant.
The eluate flow-rate was 15 mI/hr. Eluates were monitored at
254 nm and collected in 6-mI aliquots. The efficiency of desalt-
ing was checked by measurements of the conductivity of the
fractions obtained.
Prior to HPLC separation, the subfractions were recycled by
using anion-exchange and desalting procedures and then stored
in lyophilized form.
Separation of UMM by IIPLC. The isolated UMM were
anionic, thus, their separation was possible since these com-
pounds could form ion-pair complexes in the presence of
tetrabutylammonium (PlC A Reagent Waters Associates, Paris,
France) used as counter-ion.
The ion-pair complexes thus created could be isolated by
reversed-phase chromatography.
The separation was performed at 20°C with a chromatograph
(Varian, model VISTA 54) fitted with a 0.47 x 25 cm steel
column pre-packed with spherisorb C(5 .cm (Sopares-Gentilly).
The solutions of UMM and the mobile phase were prepared
with bidistillated water and filtered through a 0.2 s filter
(Millipore). An amount from 10 to 20 1d of UMM solution (2
mg/mi) was injected by means of an injector (Model Valco)
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Fig. 1. A Typical gel permeation of biological fluid. B Typical ion-
exchange separation of peak 2. Symbols are: broken line, normal
serum; solid line, uremic ultrafiltrate or normal urine.
2.5.2 2.5.3 2.5.4
included in the chromatograph. The elution at a flow-rate of 1
mi/mm was carried out by a mobile phase constituted of 0.005 frI
pH 7.6 tetrabutylammonium dissolved in a mixture of water
(75%) and methanol (25%—Uvasol Merck, Paris, France). The
eluate was monitored at 230 nm with a detector (Varian
Varichrom) equipped with an 8-1.d microcell. The chromato-
gram was recorded at the rate of 30 cm/hr.
Results. To avoid confusion we have retained the new peak
numbering system [81. Gel permeation chromatography provid-
ed 8 to 10 fractions, peak 2 (Fig. 1A), corresponding to the
UMM (peak 7 of Fürst's initial technique [71). The anion-
2.5.5 2.5.6 2.5.7 2.5.8 2.5.9 2.5.10
exchange chromatography allowed us to divide peak 2 into its
different compounds numbered 2.1, 2.2, 2.3 . . ., 2.7 (Fig. 1B).
Fraction 2.5 (elution volume 155 ml 10) whose toxicity had
been shown [9, 101 was desalted and analyzed by HPLC. In the
case of normal serum, fraction 2.5 was present only at a very
low concentration, so we obtained this fraction by collecting it
in the region where peak 2.5 is eluted (Fig. 1B). The reversed-
phase HPLC after the ion-pair complex formation permitted the
division of fraction 2.5 into ten new different compounds
numbered 2.5.1, 2.5.2 . . ., 2.5.10 (Fig. 2).
We found that proportionality did exist between the surface
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Fig. 2. Typical chromatograms of fraction 2.5. Symbols are: broken




1 8.39 9.08 10.07 11.92 12.94 13.98 15.00 16.00 18.12 25.97
2 8.44 9.12 10.06 11.89 12.92 13.97 ND ND 18.19 26.04
3 8.38 9.01 10.09 ll.84 13.00 13.96 14.95 16.03 18.15 26.01
4 8.43 9.07 10.04 11.90 12.98 13.99 15.00 15.95 18.20 25.98
5 8.44 9.13 10.07 11.86 ND 13.93 15.04 ND 18.21 26.06
6 8.40 9.13 10.08 11.85 13.00 14.02 15.07 ND 18.20 26.05
7 8.37 9.10 10.10 11.90 12.96 13.95 14.99 16.04 18.16 26.03
8 8.48 9.15 10.05 11.88 12.93 13.97 14.98 15.97 18.17 25.98
9 8.42 9.17 10.10 12.01 13.02 14.02 15.05 16.05 18.18 26.05
Normal urine 8.43 9.12 10.03 12.00 12.97 13.98 14.94 16.02 18.24 26.05
Normal
serum ND ND 10.05 11.60 12.95 13.98 ND 16.04 18.23 26.03
Mean R 8.42 9.11 10.07 11.90 12.97 13.98 15.00 16.01 18.18 26.02
so ±0.033 ±0.046 ±0.024 ±0.060 ±0.034 ±0.030 ±0.044 ±0.040 ±0.034 ±0,034
CV. 0.40 0.50 0.24 0.50 0.30 0.21 0.30 0.25 0.19 0.13
Abbreviations: SD, standard deviation = I (R — Mean R,)2N — 1 CV., coefficient of variation; ND, not detected; R, retention time.
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under the chromatogram obtained and the quantity of sample
injected. The reproducibility of our technique is shown in Table
1. The SD was calculated using the classical relationship. The
coefficient of variation is:
SDC.V = x 100 (R = Retention time).Mean R (2)
Discussion. Our HPLC technique allowed us to divide the
UMM fraction 2.5 into ten new compounds.
First, we notice that the different fractions are identical in the
nine patients and normal urine. Therefore, we can discard the
hypothesis of artifacts due, for instance, to the presence of
drugs eluted together with uremic middle molecules [1 1]. More-
over, the results in Table I show the good reproducibility of the
analysis, so the value of the coefficient of variation is always
lower than 1%.
It must be underlined that in normal serum some fractions are
present but at a very low concentration (Fig. 2). For uremic
serum and normal urine the separation performed from peak 2.5
are identical from the qualitative point of view, nevertheless,
the most important ones are 2.5.1, 2.5.3, 2.5,4, 2.5.6, and
2.5.10.
For some patients suffering from neuropathy the 2.5.6 peak
may be very important, consequently, we will have to attempt
identification of this fraction. Preliminary studies allowed us to
show that the fraction contained the following amino-acids:
aspartic acid, serin, glutamic acid, glycine, and alanine.
Therefore, our method allows us to separate fraction 2.5 of
the UMM into its various compounds. This is, of course, but a
preliminary work which should permit us to identify these
substances later.
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